Corrigendum to "Home infusion experience in patients with Pompe disease receiving avalglucosidase alfa during three clinical trials" [Molecular Genetics and Metabolism, 143 (2024) 108608].

IF 3.7 2区生物学 Q2 ENDOCRINOLOGY & METABOLISM Molecular genetics and metabolism Pub Date : 2025-01-08 DOI:10.1016/j.ymgme.2024.109006

Jordi Díaz-Manera, Derralynn Hughes, Sevim Erdem-Özdamar, Céline Tard, Anthony Béhin, Françoise Bouhour, James Davison, Si Houn Hahn, Kristina An Haack, Olivier Huynh-Ba, Magali Periquet, Swathi Tammireddy, Nathan Thibault, Tianyue Zhou, Ans T van der Ploeg

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

“Pompe病患者在三个临床试验中接受avalglucosidase alfa的家庭输液经验”的勘误表[分子遗传与代谢，143(2024)108608]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Molecular genetics and metabolism 生物-生化与分子生物学

CiteScore

5.90

自引率

7.90%

发文量

621

审稿时长

34 days

期刊介绍： Molecular Genetics and Metabolism contributes to the understanding of the metabolic and molecular basis of disease. This peer reviewed journal publishes articles describing investigations that use the tools of biochemical genetics and molecular genetics for studies of normal and disease states in humans and animal models.

期刊最新文献

Comprehensive analysis of GDF15 as a biomarker in primary mitochondrial myopathies. Exploratory metabolomic profiling of plasma and urine in patients with mucopolysaccharidosis type II (Hunter syndrome): A pilot study. Rare disorders, big challenges: Special issue on congenital disorders of glycosylation. Corrigendum to "Home infusion experience in patients with Pompe disease receiving avalglucosidase alfa during three clinical trials" [Molecular Genetics and Metabolism, 143 (2024) 108608]. Predicting liver fibrosis in Gaucher disease: Investigation of contributors and development of a clinically applicable Gaucher liver fibrosis score.